http://www.oncternal.com
Oncternal Therapeutics, Inc. Company Intro
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Industry
Healthcare
Oncternal Therapeutics, Inc. Headquaters
12230 El Camino Real
San Diego,92130
United States
Oncternal Therapeutics, Inc. Share price
22 Oct 2020 02:15 GMT
$1.7000
0.01 (0.59 %)
Oncternal Therapeutics, Inc. Market cap
$36.841 M
WMC RANKING
2020
Oncternal Therapeutics, Inc. # 205
BiotechnologyLatest Oncternal Therapeutics, Inc. News
20 Oct 2020
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...
Forma Therapeutics Holdings Inc (NASDAQ: FMTX). Immunomedics, Inc. (NASDAQ: ... Oncternal Therapeutics Inc (NASDAQ: ONCT). Opthea Limited (NASDAQ: ...
20 Oct 2020
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...
Forma Therapeutics Holdings Inc (NASDAQ: FMTX). Immunomedics, Inc. (NASDAQ: ... Oncternal Therapeutics Inc (NASDAQ: ONCT). Opthea Limited (NASDAQ: ...
20 Oct 2020
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...
Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma announced the signing of a license agreement for the commercialization of Korsuva injection for the ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Oncternal Therapeutics, Inc. | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 0 | 0 | 0 | 91.99 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 0 | 0 | 0 | 19.01 |
Oncternal Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Oncternal Therapeutics, Inc. | $2,425 | $35,533 | $-34,188 | $36.841M | 205 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |